This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shijiazhuang Pharma. Group Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Zhan-qi Niu: Innovator in Pharmaceutical Chemistry
Introduction
Zhan-qi Niu is a notable inventor based in Hebei, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on inclusion complexes. His research focuses on enhancing the solubility and therapeutic effects of butylphthalide, a compound with potential clinical applications.
Latest Patents
Zhan-qi Niu holds a patent for "Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof." This invention relates to the complexation of butylphthalide with cyclodextrin or its derivatives, specifically hydroxypropyl-β-cyclodextrin. The aim is to increase the water solubility of butylphthalide, thereby facilitating the development of various clinical formulations such as infusions, injections, and oral liquids. He has 1 patent to his name.
Career Highlights
Throughout his career, Zhan-qi Niu has worked with prominent companies in the pharmaceutical sector. He has been associated with Shijiazhuang Pharmaceutical Group and Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His work in these organizations has contributed to advancements in drug formulation and delivery systems.
Collaborations
Zhan-qi Niu has collaborated with notable colleagues, including Kai Zhao and Wen-juan Liu. These partnerships have fostered a collaborative environment that enhances research and innovation in pharmaceutical sciences.
Conclusion
Zhan-qi Niu's contributions to the field of pharmaceutical chemistry, particularly through his patent on butylphthalide inclusion complexes, highlight his role as an innovator. His work continues to influence the development of effective therapeutic formulations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile